Metraipolis › archive › dc_4aba819ddfb8

Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment — Europe PMC PMID:40938862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40938862
DOI
10.1371/journal.pone.0330841
License (as archived)
solo-consultazione
Archived
2026-11-09T23:51:34.065Z
SHA-256 of the archived text
e785ed894fa972582cc7353ea363cc1c8e18b3941f83ef82f7bd549bea468efa
Stable URL of this page
https://metraipolis.com/documento/dc_4aba819ddfb8

How to cite

Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment — Europe PMC PMID:40938862 — Europe PMC (en), https://europepmc.org/article/MED/40938862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4aba819ddfb8 (Metraipolis archive dc_4aba819ddfb8, sha256 e785ed894fa972582cc7353ea363cc1c8e18b3941f83ef82f7bd549bea468efa)
BibTeX
@misc{dc4aba819ddfb8,
  title = {Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment — Europe PMC PMID:40938862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40938862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4aba819ddfb8; sha256 e785ed894fa972582cc7353ea363cc1c8e18b3941f83ef82f7bd549bea468efa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40938862. Agents can read the archived copy with the MCP tool read_document.